Literature DB >> 24132938

Combining markers with and without the limit of detection.

Ting Dong1, Catherine Chunling Liu, Emanuel F Petricoin, Liansheng Larry Tang.   

Abstract

In this paper, we consider the combination of markers with and without the limit of detection (LOD). LOD is often encountered when measuring proteomic markers. Because of the limited detecting ability of an equipment or instrument, it is difficult to measure markers at a relatively low level. Suppose that after some monotonic transformation, the marker values approximately follow multivariate normal distributions. We propose to estimate distribution parameters while taking the LOD into account, and then combine markers using the results from the linear discriminant analysis. Our simulation results show that the ROC curve parameter estimates generated from the proposed method are much closer to the truth than simply using the linear discriminant analysis to combine markers without considering the LOD. In addition, we propose a procedure to select and combine a subset of markers when many candidate markers are available. The procedure based on the correlation among markers is different from a common understanding that a subset of the most accurate markers should be selected for the combination. The simulation studies show that the accuracy of a combined marker can be largely impacted by the correlation of marker measurements. Our methods are applied to a protein pathway dataset to combine proteomic biomarkers to distinguish cancer patients from non-cancer patients.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Keywords:  ROC curve; diagnostic accuracy; limit of detection; linear discriminant analysis

Mesh:

Substances:

Year:  2013        PMID: 24132938      PMCID: PMC4084760          DOI: 10.1002/sim.6027

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Combining diagnostic test results to increase accuracy.

Authors:  M S Pepe; M L Thompson
Journal:  Biostatistics       Date:  2000-06       Impact factor: 5.899

Review 2.  Clinical proteomics: Applications for prostate cancer biomarker discovery and detection.

Authors:  Emanuel F Petricoin; David K Ornstein; Lance A Liotta
Journal:  Urol Oncol       Date:  2004 Jul-Aug       Impact factor: 3.498

3.  On linear combinations of biomarkers to improve diagnostic accuracy.

Authors:  Aiyi Liu; Enrique F Schisterman; Yan Zhu
Journal:  Stat Med       Date:  2005-01-15       Impact factor: 2.373

4.  Receiver operating characteristic curve inference from a sample with a limit of detection.

Authors:  Neil J Perkins; Enrique F Schisterman; Albert Vexler
Journal:  Am J Epidemiol       Date:  2006-11-16       Impact factor: 4.897

5.  Combining multiple biomarker models in logistic regression.

Authors:  Zheng Yuan; Debashis Ghosh
Journal:  Biometrics       Date:  2008-03-05       Impact factor: 2.571

6.  Maximum likelihood ratio tests for comparing the discriminatory ability of biomarkers subject to limit of detection.

Authors:  Albert Vexler; Aiyi Liu; Ekaterina Eliseeva; Enrique F Schisterman
Journal:  Biometrics       Date:  2007-11-19       Impact factor: 1.701

  6 in total
  2 in total

1.  Sufficient dimension reduction for censored predictors.

Authors:  Diego Tomassi; Liliana Forzani; Efstathia Bura; Ruth Pfeiffer
Journal:  Biometrics       Date:  2016-08-09       Impact factor: 2.571

2.  Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers.

Authors:  Joshua D Cohen; Ammar A Javed; Christopher Thoburn; Fay Wong; Jeanne Tie; Peter Gibbs; C Max Schmidt; Michele T Yip-Schneider; Peter J Allen; Mark Schattner; Randall E Brand; Aatur D Singhi; Gloria M Petersen; Seung-Mo Hong; Song Cheol Kim; Massimo Falconi; Claudio Doglioni; Matthew J Weiss; Nita Ahuja; Jin He; Martin A Makary; Anirban Maitra; Samir M Hanash; Marco Dal Molin; Yuxuan Wang; Lu Li; Janine Ptak; Lisa Dobbyn; Joy Schaefer; Natalie Silliman; Maria Popoli; Michael G Goggins; Ralph H Hruban; Christopher L Wolfgang; Alison P Klein; Cristian Tomasetti; Nickolas Papadopoulos; Kenneth W Kinzler; Bert Vogelstein; Anne Marie Lennon
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.